0000950170-24-025870.txt : 20240305 0000950170-24-025870.hdr.sgml : 20240305 20240305160521 ACCESSION NUMBER: 0000950170-24-025870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Germa Caroline CENTRAL INDEX KEY: 0002013288 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40287 FILM NUMBER: 24720251 MAIL ADDRESS: STREET 1: IKENA ONCOLOGY, INC. STREET 2: 645 SUMMER STREET, SUITE 101 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ikena Oncology, Inc. CENTRAL INDEX KEY: 0001835579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-343-8292 MAIL ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 4 1 ownership.xml 4 X0508 4 2024-03-01 0001835579 Ikena Oncology, Inc. IKNA 0002013288 Germa Caroline C/O IKENA ONCOLOGY, INC. 645 SUMMER STREET, SUITE 101 BOSTON MA 02210 false true false false Chief Medical Officer false Stock Option (Right to Buy) 1.47 2024-03-01 4 A false 579100 0.00 A 2034-03-01 Common Stock 579100 579100 D 12.5% of the shares subject to this option shall vest and become exercisable on September 1, 2024, with the remainder vesting in forty-two (42) equal monthly installments thereafter. /s/ Mark Manfredi, as Attorney-in-Fact for Caroline Germa 2024-03-05